Clinicians should think about molecular characterization of HGPIN as a way to boost risk stratification. == Launch == Prostate cancers (PCa) may be the second leading reason behind cancer fatalities among men in america, with an expected 30,000 fatalities each full year.1One from the determinants of the patient’s risk for having or developing PCa, separate […]